Estrogen attenuates integrin-β3-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells

Circulation

Volumn 101, Issue 25, 2000, Pages 2949-2955

  Li, Guohong ^a,b   Chen, Yiu Fai ^a   Kelpke, Stacey S ^a   Oparil, Suzanne ^a   Thompson, John A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b 1034 Zeigler Research Bldg   (United States)

Author keywords

Cells; Hormones; Integrins; Muscle, smooth; Osteopontin; Vasculature

Indexed keywords

BETA1 INTEGRIN; ESTROGEN; INTEGRIN; INTEGRIN RECEPTOR; OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL INJURY; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTER; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

EID: 0034720828     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.25.2949     Document Type: Article

References (28)

1. Shi Y, O'Brien JE Jr, Fard A, et al. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996;94:1655-1664.
2. Zalewski A, Shi Y. Vascular myofibroblasts: lessons from coronary repair and remodeling. Arterioscler Thromb Vasc Biol. 1997;17:417-422.
3. Shi Y, O'Brien JE Jr, Ala-Kokko L, et al. Origin of extracellular matrix synthesis during coronary repair. Circulation. 1997;95:997-1006.
4. Shi Y, Pieniek M, Fard A, et al. Adventitial remodeling after coronary arterial injury. Circulation. 1996;93:340-348.
5. Scott NA, Cipolla GD, Ross CE, et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996;93:2178-2187.
6. Oparil S, Chen SJ, Chen YF, et al. Estrogen attenuates the adventitial contribution to neointima formation in injured rat carotid arteries. Cardiovasc Res. 1999;44:608-614.
7. Li G, Chen YF, Greene GL, et al. Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro. Circulation. 1999;100:1639-1645.
8. Boudreau NJ, Jones PL. Extracellular matrix and integrin signalling: the shape of things to come. Biochem J. 1999;339(pt 3):481-488.
9. Itoh H, Nelson PR, Mureebe L, et al. The role of integrins in saphenous vein vascular smooth muscle cell migration. J Vasc Surg. 1997;25: 1061-1069.
10. Crowe DL, Shuler CF. Regulation of tumor cell invasion by extracellular matrix. Histol Histopathol. 1999;14:665-671.
11. Giachelli CM, Bae N, Almeida M, et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
12. Wang X, Louden C, Ohlstein EH, et al. Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty. Arterioscler Thromb Vasc Biol. 1996;16:1365-1372.
13. Srivatsa SS, Fitzpatrick LA, Tsao PW, et al. Selective ανβ3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin ανβ3 and osteopontin expression during neointima formation. Cardiovasc Res. 1997;36:408-428.
14. Liaw L, Lombardi DM, Almeida MM, et al. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler Thromb Vasc Biol. 1997;17: 188-193.
15. Choi ET, Engel L, Vallow AD, et al. Inhibition of neointimal hyperplasia by blocking alpha ν beta 3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surgery. 1994;19:125-134.
16. Matsuno H, Stassen JM, Vermylen J, et al. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 1994;90:2203-2206.
17. Elgavish A, Prince C, Chang PL, et al. Osteopontin stimulates a sub-7 population of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro. Prostate. 1998;35:83-94.
18. Ross R. Growth of smooth muscle cell in culture and formation of elastic fibers. J Cell Biol. 1971;50:172-186.
19. Thompson JA, Haudenschild CC, Anderson KD, et al. Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc Natl Acad Sci U S A. 1989;86:7928-7939.
20. Opalenik SR, Shin JT, Wehby JN, et al. The HIV-1 TAT protein induces the expression and extracellular appearance of acidic fibroblast growth factor. J Biol Chem. 1995;270:1745-1746.
21. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res. 1990;50:1774-1778.
22. Veinot JP, Srivatsa S, Carlson P. Beta3 integrin: a promiscuous integrin involved in vascular pathology. Can J Cardiol. 1999;15:762-770.
23. Weintraub AS, Giachelli CM, Krauss RS, et al. Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels. Am J Pathol. 1996;149:259-272.
24. Liaw L, Skinner MP, Raines EW, et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins: role of alphaν beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest. 1995;95:713-724.
25. Nelson PR, Yamamura S, Kent KC. Extracellular matrix proteins are potent agonists of human smooth muscle cell migration. J Vasc Surg. 1996;24:25-33.
26. Eliceiri BP, Cheresh DA. The role of αν integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest. 1999;103:1227-1230.
27. Hynes RO. Integrins: variety, versatility, and interactions in cell adhesions. Cell. 1992;69:11-25.
28. 1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration. Circulation. 1998;97:1818-1827.